Abstract
Background
The increasing global incidence and prevalence of inflammatory bowel disease (IBD) necessitates an investigation into the potential influence of environmental risk factors on its origin.
Aim
This multicenter case-control study aimed to investigate potential environmental risk factors contributing to IBD development in Turkey.
Methods
The study included 156 Crohn’s disease (CD), 277 ulcerative colitis (UC) patients, and 468 controls (matched for age and gender) from six hospitals’ gastroenterology departments. Data collection relied on the International Organization of IBD’s questionnaire on environmental factors. Each environmental factor was initially analyzed using univariate and subsequently multivariate logistic regression models.
Results
In the multivariate model, regular coffee consumption was associated with decreased odds for both CD (OR 0.28; 95% CI 0.14–0.55) and UC (OR 0.25; 95% CI 0.15–0.42). Stress was associated with UC (OR 3.27; 95% CI 1.76–6.10) and CD (OR 4.40; 95% CI 2.12–9.10) development. A history of childhood infectious diseases (gastroenteritis, upper respiratory tract infections, etc.) raised the odds for both CD (OR 9.45; 95% CI 2.51–35.6) and UC (OR 7.56; 95% CI 1.57–36.4). Conversely, consuming well/spring water (OR 0.22; 95% CI 0.10–0.50) and childhood antibiotic use (OR 0.41; 95% CI 0.18–0.93) showed a positive association against UC. Increased consumption of refined sugar and industrial food products emerged as risk factors for IBD. Smoking increased the risk for CD (OR 2.38; 95% CI 1.16–4.91), while ex-smoking increased the risk for UC (OR 3.16; 95% CI 1.19–8.37).
Conclusions
This study represents the first multicenter case–control study in Turkey examining the effects of environmental factors on IBD. It revealed that coffee consumption is positively associated, while stress and childhood infection-related diseases are risk factors. These findings, which are not supported by other studies, provide insight into the relationships between these factors and IBD.
Similar content being viewed by others
References
Ponder A, Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol. 2013;5:237–247. https://doi.org/10.2147/CLEP.S33961.
GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:17–30. https://doi.org/10.1016/S2468-1253(19)30333-4.
Ng SC, Shi HY, Hamidi N et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769–2778. https://doi.org/10.1016/S0140-6736(17)32448-0.
Ahuja V, Tandon RK. Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences. J Dig Dis. 2010;11:134–147. https://doi.org/10.1111/j.1751-2980.2010.00429.x.
Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794. https://doi.org/10.1053/j.gastro.2011.01.055.
Molodecky NA, Soon IS, Rabi DM et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46-e30. https://doi.org/10.1053/j.gastro.2011.10.001.
Dagli U (2008) Epidemiology and genetics of inflammatory bowel disease in Turkey. Proceedings of the falk symposium 159 on IBD 2007 achievements in research and clinical practice; 2007 May 4–5; Istanbul, Turkey. Falk symposium abstracts book of ınvited lectures, pp. 25–26
Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am. 2020;49:643–654. https://doi.org/10.1016/j.gtc.2020.07.005.
Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet. 2017;389:1741–1755. https://doi.org/10.1016/S0140-6736(16)31711-1.
Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462–1471. https://doi.org/10.4065/81.11.1462.
Ng SC, Bernstein CN, Vatn MH et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62:630–649. https://doi.org/10.1136/gutjnl-2012-303661.
Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010;105:2687–2692. https://doi.org/10.1038/ajg.2010.398.
Ungaro R, Bernstein CN, Gearry R et al. Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol. 2014;109:1728–1738. https://doi.org/10.1038/ajg.2014.246.
Vedamurthy A, Ananthakrishnan AN. Influence of environmental factors in the development and outcomes of ınflammatory bowel disease. Gastroenterol Hepatol (NY). 2019;15:72–82.
Ng SC, Tang W, Leong RW et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut. 2015;64:1063–1071. https://doi.org/10.1136/gutjnl-2014-307410.
Halfvarson J, Jess T, Magnuson A et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish–Danish twin population. Inflamm Bowel Dis. 2006;12:925–933. https://doi.org/10.1097/01.mib.0000228998.29466.ac.
Chowdhury MZI, Turin TC. Variable selection strategies and its importance in clinical prediction modelling. Fam Med Community Health. 2020;8:e000262. https://doi.org/10.1136/fmch-2019-000262.
Axelrad JE, Cadwell KH, Colombel JF, Shah SC. The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review. Therap Adv Gastroenterol. 2021;14:17562848211004492. https://doi.org/10.1177/17562848211004493.
Singh N, Bernstein CN. Environmental risk factors for inflammatory bowel disease. United Eur Gastroenterol J. 2022;10:1047–1053. https://doi.org/10.1002/ueg2.12319.
Faye AS, Allin KH, Iversen AT et al. Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study. Gut. 2023;72:663–670. https://doi.org/10.1136/gutjnl-2022-327845.
Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Lytras T, Bonovas S. Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterology. 2019;157:647-659.e4. https://doi.org/10.1053/j.gastro.2019.04.016.
Agrawal M, Sabino J, Frias-Gomes C et al. Early life exposures and the risk of inflammatory bowel disease: systematic review and meta-analyses. EClinicalMedicine. 2021;36:100884. https://doi.org/10.1016/j.eclinm.2021.100884.
Baron S, Turck D, Leplat C et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut. 2005;54:357–363. https://doi.org/10.1136/gut.2004.054353.
Lee IA, Low D, Kamba A, Llado V, Mizoguchi E. Oral caffeine administration ameliorates acute colitis by suppressing chitinase 3-like 1 expression in intestinal epithelial cells. J Gastroenterol. 2014;49:1206–1216. https://doi.org/10.1007/s00535-013-0865-3.
Bianchi Porro G, Panza E. Smoking, sugar, and inflammatory bowel disease. Br Med J (Clin Res Ed). 1985;291:971–972. https://doi.org/10.1136/bmj.291.6500.971-c.
Hansen TS, Jess T, Vind I et al. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis. 2011;5:577–584. https://doi.org/10.1016/j.crohns.2011.05.010.
Jakobsen C, Paerregaard A, Munkholm P, Wewer V. Environmental factors and risk of develo** paediatric inflammatory bowel disease—a population based study 2007–2009. J Crohns Colitis. 2013;7:79–88. https://doi.org/10.1016/j.crohns.2012.05.024.
Russel MG, Engels LG, Muris JW et al. Modern life’ in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol. 1998;10:243–249. https://doi.org/10.1097/00042737-199803000-00010.
Khalili H, Chan SSM, Lochhead P, Ananthakrishnan AN, Hart AR, Chan AT. The role of diet in the aetiopathogenesis of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2018;15:525–535. https://doi.org/10.1038/s41575-018-0022-9.
Altajar S, Moss A. Inflammatory bowel disease environmental risk factors: diet and gut microbiota. Curr Gastroenterol Rep. 2020;22:57. https://doi.org/10.1007/s11894-020-00794-y.
Bisgaard TH, Allin KH, Keefer L, Ananthakrishnan AN, Jess T. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment. Nat Rev Gastroenterol Hepatol. 2022;19:717–726. https://doi.org/10.1038/s41575-022-00634-6.
Luo J, Xu Z, Noordam R, van Heemst D, Li-Gao R. Depression and inflammatory bowel disease: a bidirectional two-sample mendelian randomization study. J Crohns Colitis. 2022;16:633–642. https://doi.org/10.1093/ecco-jcc/jjab191.
Gao X, Tang Y, Lei N et al. Symptoms of anxiety/depression is associated with more aggressive inflammatory bowel disease. Sci Rep. 2021;11:1440. https://doi.org/10.1038/s41598-021-81213-8.
Nicolaides S, Vasudevan A, Long T, van Langenberg D. The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease. Intest Res. 2021;19:158–170. https://doi.org/10.5217/ir.2020.00008.
Acknowledgments
We extend our heartfelt thanks to everyone who contributed to the implementation and completion of the questionnaires, which are the most crucial factor for this article.
Author information
Authors and Affiliations
Contributions
Study concept and design: C. Cansu Alperen and Ulku Dagli. Data acquisition: C. Cansu Alperen. Contribution to patient sharing and data collection process: Baris Soydas, Ender Serin, Mustafa Erbayrak, Nurten A. Savas, Gulhan K. Unler, Cenk Emre Meral, Ahmet Sedat Boyacioglu. Data analysis: Ugur Toprak, C. Cansu Alperen. Interpretation of data: C. Cansu Alperen, Ugur Toprak, Ulku Dagli. Drafting of the manuscript: C. Cansu Alperen. Critical revision and approval: Ulku Dagli and C. Cansu Alperen.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no confict of interest.
Ethical approval
Ethical approval from Başkent University Faculty of Medicine Research and Ethics Committee (Project No. KA20/306) validated the research’s scientific and ethical basis.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Alperen, C.C., Soydas, B., Serin, E. et al. Role of Environmental Risk Factors in the Etiology of Inflammatory Bowel Diseases: A Multicenter Study. Dig Dis Sci (2024). https://doi.org/10.1007/s10620-024-08491-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10620-024-08491-w